Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Design of micro, nanoparticles to improve treatments for Alzheimer's, Parkinson's

  • Sexual preference for masculine men, feminine women is an urban habit

  • Why your brain makes you reach for junk food

  • Siblings of children with autism can show signs at 18 months

  • Positive subliminal messages on aging improve physical functioning in elderly

  • Scientists restore hearing in noise-deafened mice, pointing way to new therapies

  • See-through sensors open new window into the brain

  • Untangling the biological effects of blue light

  • Mental rest and reflection boost learning, study suggests

  • Pathological gambling is associated with altered opioid system in the brain: Reduced feeling of euphoria when compared to healthy volunteers

  •